Effective factors in peripheral seizure production in patients undergoing Electroconvulsive Therapy from anesthesia perspective

Message:
Abstract:
Aim and
Background
Electroconvulsive therapy(ECT) is one of the most effective and prompt therapies for severe psychotic issues. This study aims to distinguish the impact of age, disease and medications on the seizure caused by ECT. Methods and Materials: 123 patients were studied and categorized according to their age, psychotic disorder and medications (anti-psychotics, anti-depressive or both of them). The correlation of these variants with seizure duration were discussed in every session of ECT.The seizure duration was recorded based on clinical convulsion and EEG parameters. The failure or success of ECT was evaluated by seizure time measurement to be less or greater than 20 sec, respectively.
Findings
There was no significant difference observed between men and women in regards to the average seizure duration in different sessions (6 sessions) (P=0.25).There was either no significant difference observed in seizure duration in various sessions between patients under and above 40 years of ag (P=0.45). Again no significant difference was seen in seizure duration among patients with psychotic and mood disorders or between patients using anti-psychotic or anti- psychotic and anti- depressant drugs for therapy, respectively (P=0.38 and P=0.14).
Conclusions
Accurate knowledge about patients who are candidate to receive Electroconvulsive Therapy is very important. Type of psychologic disorder, type of drug protocol and the number of sessions of ECT, all are the factors which should be considered in every ECT procedure.
Language:
Persian
Published:
Journal of Anesthesiology and Pain, Volume:6 Issue: 2, 2015
Pages:
11 to 20
magiran.com/p1418523  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!